Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient

• Hauptverfasser: Sineida Berbert Ferreira (Verfasst von), Rachel Berbert Ferreira (Verfasst von), Afonso Cesar Neves Neto (Verfasst von), Silvana Martins Caparroz Assef (Verfasst von), Morton Scheinberg (Verfasst von)
• Format: Buch
• Veröffentlicht: Karger Publishers, 2021-04-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Vitiligo is an autoimmune skin disease presenting with areas of depigmentation. Recent reports suggest that Janus kinase (JAK) inhibitors may be an effective therapy. In this case report, we show our experience with an adolescent patient with a long history of generalized and refractory vitiligo, fo...